Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Bärnthaler, T; Jandl, K; Sill, H; Uhl, B; Schreiber, Y; Grill, M; Thomas, D; Schicho, R; Marsche, G; Frank, S; Heinemann, A; Schuligoi, R.
Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation.
J Allergy Clin Immunol. 2019; 143(2):794-797
Doi: 10.1016/j.jaci.2018.09.030
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Bärnthaler Thomas
-
Schuligoi Rufina
- Co-authors Med Uni Graz
-
Frank Sasa
-
Grill Magdalena
-
Heinemann Akos
-
Jandl Katharina
-
Marsche Gunther
-
Schicho Rudolf
-
Sill Heinz
-
Uhl Barbara
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Abelson murine leukemia virus - physiology
-
Cytokines - metabolism
-
Dinoprostone - metabolism
-
Humans -
-
Imatinib Mesylate - pharmacology
-
Inflammation -
-
Leukemia - drug therapy
-
Leukemia - genetics
-
Leukemia - immunology
-
Lipopolysaccharides - immunology
-
Monocytes - drug effects
-
Monocytes - physiology
-
NF-kappa B - metabolism
-
Philadelphia Chromosome -
-
Platelet Activation -
-
Proto-Oncogene Proteins c-bcr - genetics
-
Receptors, Prostaglandin E, EP4 Subtype - metabolism
-
Signal Transduction -
-
Th1-Th2 Balance -
-
Thromboxane A2 - metabolism
-
U937 Cells -